Order Article Reprints

Nakajima H, Okada H, Kogure A, Osaka T, Tsutsumi T, Tanaka T, Hasegawa G, Mogami S, Mitsuhashi K, Kitagawa N, et al. Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study. Diabetology. 2022; 3(4):620-633. https://doi.org/10.3390/diabetology3040048

Nakajima, Hanako, Hiroshi Okada, Akinori Kogure, Takafumi Osaka, Takeshi Tsutsumi, Toru Tanaka, Goji Hasegawa, Shinichi Mogami, Kazuteru Mitsuhashi, Noriyuki Kitagawa, and et al. 2022. "Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study" Diabetology 3, no. 4: 620-633. https://doi.org/10.3390/diabetology3040048

Nakajima, H., Okada, H., Kogure, A., Osaka, T., Tsutsumi, T., Tanaka, T., Hasegawa, G., Mogami, S., Mitsuhashi, K., Kitagawa, N., Hashimoto, Y., Yano, M., Tanaka, M., Kitamura, A., Ishii, M., Nakamura, N., Kishi, A., Ushigome, E., Hamaguchi, M., & Fukui, M. (2022). Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study. Diabetology, 3(4), 620-633. https://doi.org/10.3390/diabetology3040048